- Home
- VNRX vs NXN Comparison
VNRX vs NXN Comparison
Compare VNRX & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- NXN
- Stock Information
- Founded
- VNRX N/A
- NXN 1992
- Country
- VNRX United States
- NXN United States
- Employees
- VNRX N/A
- NXN N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NXN Trusts Except Educational Religious and Charitable
- Sector
- VNRX Health Care
- NXN Finance
- Exchange
- VNRX Nasdaq
- NXN Nasdaq
- Market Cap
- VNRX 58.6M
- NXN 46.0M
- IPO Year
- VNRX N/A
- NXN N/A
- Fundamental
- Price
- VNRX $0.55
- NXN $11.67
- Analyst Decision
- VNRX Strong Buy
- NXN
- Analyst Count
- VNRX 4
- NXN 0
- Target Price
- VNRX $4.17
- NXN N/A
- AVG Volume (30 Days)
- VNRX 106.5K
- NXN 9.7K
- Earning Date
- VNRX 05-12-2025
- NXN 01-01-0001
- Dividend Yield
- VNRX N/A
- NXN 4.23%
- EPS Growth
- VNRX N/A
- NXN N/A
- EPS
- VNRX N/A
- NXN 0.24
- Revenue
- VNRX $1,285,827.00
- NXN N/A
- Revenue This Year
- VNRX $71,446.31
- NXN N/A
- Revenue Next Year
- VNRX N/A
- NXN N/A
- P/E Ratio
- VNRX N/A
- NXN $48.42
- Revenue Growth
- VNRX 97.50
- NXN N/A
- 52 Week Low
- VNRX $0.43
- NXN $10.64
- 52 Week High
- VNRX $1.04
- NXN $12.45
- Technical
- Relative Strength Index (RSI)
- VNRX 44.08
- NXN 52.27
- Support Level
- VNRX $0.55
- NXN $11.70
- Resistance Level
- VNRX $0.65
- NXN $11.88
- Average True Range (ATR)
- VNRX 0.04
- NXN 0.12
- MACD
- VNRX -0.00
- NXN -0.01
- Stochastic Oscillator
- VNRX 16.00
- NXN 25.81
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.